Pfizer-BioNTech Vaccine Effectiveness Comparable in IBD Patients, General Population Pfizer-BioNTech Vaccine Effectiveness Comparable in IBD Patients, General Population

Preliminary real-world data from Israel show that COVID-19 vaccine effectiveness in patients with IBD was comparable to that of the general population, researchers say.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news